Your browser doesn't support javascript.
loading
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial.
Gallagher, Rosa I; Wulfkuhle, Julia; Wolf, Denise M; Brown-Swigart, Lamorna; Yau, Christina; O'Grady, Nicholas; Basu, Amrita; Lu, Ruixiao; Campbell, Michael J; Magbanua, Mark J; Coppé, Jean-Philippe; Asare, Smita M; Sit, Laura; Matthews, Jeffrey B; Perlmutter, Jane; Hylton, Nola; Liu, Minetta C; Symmans, W Fraser; Rugo, Hope S; Isaacs, Claudine; DeMichele, Angela M; Yee, Douglas; Pohlmann, Paula R; Hirst, Gillian L; Esserman, Laura J; van 't Veer, Laura J; Petricoin, Emanuel F.
Afiliação
  • Gallagher RI; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA. Electronic address: rgallag3@gmu.edu.
  • Wulfkuhle J; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA. Electronic address: jwulfkuh@gmu.edu.
  • Wolf DM; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Brown-Swigart L; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Yau C; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • O'Grady N; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Basu A; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Lu R; Quantum Leap Healthcare Collaborative, San Francisco, CA 94118, USA.
  • Campbell MJ; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Magbanua MJ; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Coppé JP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Asare SM; Quantum Leap Healthcare Collaborative, San Francisco, CA 94118, USA.
  • Sit L; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Matthews JB; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Perlmutter J; Gemini Group, Ann Arbor, MI 48107, USA.
  • Hylton N; Department of Radiology, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Liu MC; Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Symmans WF; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Rugo HS; Division of Hematology/Oncology, University of California, San Francisco, San Francisco, CA 94158, USA.
  • Isaacs C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA.
  • DeMichele AM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
  • Yee D; Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
  • Pohlmann PR; Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Hirst GL; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Esserman LJ; Department of Surgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • van 't Veer LJ; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA 20110, USA. Electronic address: epetrico@gmu.edu.
Cell Rep Med ; 4(12): 101312, 2023 12 19.
Article em En | MEDLINE | ID: mdl-38086377
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Neoplasias de Mama Triplo Negativas Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Neoplasias de Mama Triplo Negativas Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article